600873 梅花生物
按盤價 
10.220 -0.040 (-0.390%) | 2025/09 - 九個月 人民幣(K¥) | 與去年同期 比較 | 2024/12 人民幣(K¥) | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | ||
| 營業總收入 | 18,215,447 | -2.49% | 25,069,288 | 27,760,612 | 27,937,153 | 23,060,956 | |
| 減：營業總成本 | 15,834,728 | -4.89% | 21,862,600 | 24,158,623 | 22,990,081 | 20,420,447 | |
| 其中:營業成本 | 14,342,186 | -5.33% | 20,036,699 | 22,297,122 | 20,915,784 | 18,585,713 | |
| 財務費用 | (13,954) | -80.54% | (117,264) | (33,427) | 83,877 | 176,935 | |
| 資產減值損失 | (9,348) | 403.30% | (6,982) | (5,415) | (5,958) | (20,500) | |
| 公允價值變動收益 | 25,374 | 189.56% | 14,826 | (38,116) | 32,687 | (22,024) | |
| 投資收益 | 42,049 | 102.72% | 30,193 | 7,627 | 24,365 | 307,906 | |
| 其中：對聯營企業和合營企業的投資收益 | (2,035) | -51.04% | (3,018) | 1,846 | 3,074 | (354) | |
| 營業利潤 | 2,658,930 | 16.94% | 3,491,285 | 3,813,393 | 5,160,179 | 2,929,432 | |
| 利潤總額 | 3,442,505 | 46.99% | 3,349,461 | 3,723,136 | 5,152,795 | 2,883,412 | |
| 減：所得稅費用 | 417,412 | 20.42% | 609,033 | 542,186 | 746,553 | 456,108 | |
| 淨利潤 | 3,025,092 | 51.61% | 2,740,427 | 3,180,950 | 4,406,242 | 2,427,304 | |
| 減：非控股權益 | -- | -- | -- | -- | -- | 25,056 | |
| 股東淨利潤 | 3,025,092 | 51.61% | 2,740,427 | 3,180,950 | 4,406,242 | 2,402,248 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 1.060 | 55.88% | 0.940 | 1.060 | 1.440 | 0.780 | |
| 每股派息 (元) * | -- | -- | 0.602 | 0.420 | 0.400 | 0.400 | |
| 每股淨資產 (元) * | 5.747 | 11.39% | 5.109 | 4.812 | 4.442 | 3.428 | |
| 審計意見 # | -- | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 即時報價更新時間為 29/12/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
